5FI2

Crystal structure of human GAC in complex with inhibitor UPGL_00009: 2-phenyl-~{N}-[5-[[(3~{R})-1-[5-(2-phenylethanoylamino)-1,3,4-thiadiazol- 2-yl]pyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]ethanamide

Changes made to a PDB entry after its initial release are considered to be either “major” or “minor”. The latest minor version of each major version is available as a file download. More information about the PDB versioning is available.

Version Number	Version Date	Version Type/Reason	Version Change	Revised CIF Category
1.0	2016-05-11	Initial release
1.1	2017-09-20		Advisory, Author supporting evidence, Database references, Derived calculations	citation, pdbx_audit_support, pdbx_struct_oper_list, pdbx_unobs_or_zero_occ_atoms
1.2	2019-12-25		Author supporting evidence	pdbx_audit_support
1.3	2023-09-27		Advisory, Data collection, Database references, Refinement description	chem_comp_atom, chem_comp_bond, database_2, pdbx_initial_refinement_model, pdbx_unobs_or_zero_occ_atoms	Download

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.